Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules

This publication has 117 references indexed in Scilit:

• Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer
  International Journal of Oncology, 2013
• Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells
  Journal of Biological Chemistry, 2012
• Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
  Annals of Oncology, 2011
• Proinflammatory cytokines and thrombomodulin in patients with peptic ulcer disease and gastric cancer, infected with Helicobacter pylori
  Indian Journal of Pathology and Microbiology, 2011
• Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
  BMC Cancer, 2010
• Increased Expression of Fractalkine is Correlated with a Better Prognosis and an Increased Number of Both CD8+ T Cells and Natural Killer Cells in Gastric Adenocarcinoma
  Annals of Surgical Oncology, 2008
• Gene expression profiling in human gastric mucosa infected with Helicobacter pylori
  Laboratory Investigation, 2007
• CXCL5 overexpression is associated with late stage gastric cancer
  Journal of Cancer Research and Clinical Oncology, 2007
• Helicobacter pylori-secreting protein Tipα is a potent inducer of chemokine gene expressions in stomach cancer cells
  Journal of Cancer Research and Clinical Oncology, 2006
• New tumor necrosis factor-?-inducing protein released from Helicobacter pylori for gastric cancer progression
  Journal of Cancer Research and Clinical Oncology, 2004